Delivery Order SPE2DB24D9105-SPE2DB25FBYVM
- Not listed
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication, with a period of performance through August 5, 2024. This delivery order contract was issued under DMS Pharmaceutical Group's existing, single-award indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,013.90, is for the delivery of 4565030359 - LENVIMA 18 MG DAILY DOSE 90S, with a completion date of July 19, 2024. This award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product LENVIMA 10 MG DAILY DOSE 30S. The contract has a completion date of March 1, 2024 and a potential value of $10,662.16. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery contract 4600082013 with DLA, valued at up to $4,999,999, which enables DLA to order a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of LENVIMA 20MG DAILY 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $42,648.64, is for the provision of Lenvima 10 mg daily dose 30s, a prescription medication. This delivery order falls under a larger DLA IDV (Indefinite Delivery Vehicle) contract, number 4600082013, valued up to $4,999,999 through 2025, which enables the agency to issue orders for a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 12 mg daily dose 90 tablets. It is issued under a larger DLA Indefinite Delivery Contract (IDC), valued at $499,999,999, that enables the DLA to place delivery orders for a comprehensive range of pharmaceutical products to support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply the pharmaceutical product LENVIMA 18 MG DAILY DOSE 90S. The contract has a potential value of $21,324.32 and a completion date of January 22, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product LENVIMA 10 MG DAILY DOSE 30S. The contract has a potential value of $10,662.16 and a completion date of January 17, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical supplies to the federal government, primarily the Department of Defense,...
- SPE2DB24D9105Indefinite Delivery Contract
- SPE2DB24D9105-SPE2DB25FBYVMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a qualified federal supplier. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion blanket contract valid through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems nationwide. The company's extensive contract portfolio with the DLA demonstrates its established capability in delivering specialized pharmaceutical products, including oncology treatments, immunizations, and other prescription medications to Department of Defense healthcare sites worldwide. This LENVIMA delivery order exemplifies the company's role in ensuring reliable pharmaceutical supply to government medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/28/25 |